# Bioequivalence Study of UHAC 62 XX Tablets Compared With Capsules in Healthy Volunteers

> **NCT02180490** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 60 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** UHAC 62 XX tablet
- **DRUG:** UHAC 62 XX capsule

## Key facts

- **NCT ID:** NCT02180490
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-05
- **Primary completion:** 2002-07
- **Final completion:** —
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2014-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02180490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02180490, "Bioequivalence Study of UHAC 62 XX Tablets Compared With Capsules in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02180490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*